Characterization of Interleukin-33 and Soluble ST2 in Serum and Their Association with Disease Severity in Patients with Chronic Kidney Disease

Interleukin-33, a Target of Parathyroid Hormone and Oncostatin M, Increases Osteoblastic Matrix Mineral Deposition and Inhibits Osteoclast Formationin Vitro

(2011) Hasnawati Saleh et al.   ENDOCRINOLOGY

IL-33 Shifts the Balance from Osteoclast to Alternatively Activated Macrophage Differentiation and Protects from TNF- -Mediated Bone Loss

(2011) M. M. Zaiss et al.   JOURNAL OF IMMUNOLOGY

Treatment Strategies and Clinical Trial Design in ADPKD

(2010) Vicente E. Torres   ADVANCES IN CHRONIC KIDNEY DISEASE

Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis

(2010) Luca Pastorelli et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Potential Role of Soluble ST2 Protein in Idiopathic Nephrotic Syndrome Recurrence Following Kidney Transplantation

(2009) Sarah Bruneau et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis

(2009) Gaby Palmer et al.   ARTHRITIS AND RHEUMATISM

CRP Polymorphisms and Progression of Chronic Kidney Disease in African Americans

(2009) A. M. Hung et al.   Clinical Journal of the American Society of Nephrology

The cytokine interleukin-33 mediates anaphylactic shock

(2009) P. N. Pushparaj et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus

(2009) M. Y. Mok et al.   RHEUMATOLOGY

Cytokine Dysregulation in Chronic Kidney Disease: How Can We Treat It?

(2008) Juan Jesus Carrero et al.   BLOOD PURIFICATION

Increased Plasma Concentrations of Soluble ST2 are Predictive for 1-Year Mortality in Patients with Acute Destabilized Heart Failure

(2008) T. Mueller et al.   CLINICAL CHEMISTRY

Aspects of Immune Dysfunction in End-stage Renal Disease

(2008) S. Kato et al.   Clinical Journal of the American Society of Nephrology

FGF-23–Klotho signaling stimulates proliferation and prevents vitamin D–induced apoptosis

(2008) Damian Medici et al.   JOURNAL OF CELL BIOLOGY

The IL-33/ST2 pathway: therapeutic target and novel biomarker

(2008) Rahul Kakkar et al.   NATURE REVIEWS DRUG DISCOVERY

IL-33 exacerbates antigen-induced arthritis by activating mast cells

(2008) D. Xu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA